Call for Abstracts
The Committee of the 63rd Annual Meeting of the JSN encourages abstract submission widely from overseas. All the abstracts submitted are rated and selected for presentation by the Committee.
The abstract is only submitted by online. The submission of abstracts by e-mail will NOT be considered. The abstract should be written in English.
Regular Submission
Dec. 10 (Tue), 2019 - at 2:00 p.m. JST on Jan. 31 (Fri), 2020
Regular Submission
The deadline for regular submission is scheduled at 2:00 p.m. JST on Jan. 31 (Fri), 2020.
Please select preferred presentation style, Oral or Poster, when you submit an abstract.
However, please note that the presentation style will be decided by the congress chairperson.
Please be aware that encore abstracts will NOT be accepted.
【Best Abstract Awards】
All the abstracts submitted are rated by the Abstract Review Committee and the Committee honors high scored abstracts with Best abstract awards.
The awardees are to present their research in English both as Oral presentations and Posters. Their posters will be posted as plenary posters for 3 days during the meeting period.
The secretariat office will contact the awardees with the details.
■Call for Late Breaking Abstracts
The JSN 2020 offers a call for late breaking abstract submissions as an opportunity to share researches that are completed after the regular submission deadline and the latest research results.
(1) Abstracts and presentation (Oral and Poster) must be made in English. Their posters will be posted as plenary posters for 3 days during the meeting period.
(2) Submission period: March 2 (Mon) –at 2:00 p.m. JST on Mar. 16 (Mon)
(3) Fill out the application form, E-mail to congress secretariat below.
E-mail:jsn63@umin.ac.jp
(4) The abstracts submitted as regular submission will not be accepted.
(5) As for the abstracts accepted as Late Breaking Abstracts, only titles, authors, affiliations will be shown on the digital abstract books and the program books. The abstract body will not be published.
(6) The abstracts that are not applicable for the purpose of the session will be rejected.
*Application Review Considerations
All abstracts will be reviewed in the same manner. Abstract acceptance is determined by the Congress Chairperson 2020, based on the reviews from the Abstract Review Committee commissioned by the Congress Chairperson.
Please note that the congress will not offer the authors of regular submission any grants. The accepted authors are requested to bear all expenses to attend the congress such as their transportation, accommodation and registration.
1. Maximum number of authors and institutions
Authors: 18 persons (including the first author)
Institutions: 10 centers
2. Limitations of number of words
Abstract Title: 50 words
Abstract Body: 250 words
Total number of words (including authors, institutions, title and abstract body): 300 words
3. COI disclosure
You are requested to show whether there is any conflicts of interest on medical researches and publications by clicking a check box when your abstract submission.
Please refer to the detailed regulations
4. Password
To create your password is required. Password should be case-sensitive and must be between 6 and 8 character long. The password is necessary for you to view or modify your abstract.
For security reason, we cannot tell anyone's password. Please make sure to make a copy or back up of your password when submitting an abstract.
5. Receipt of Abstract / Notifying the result
Receipt of abstract will be automatically sent to the registered e-mail address. We strongly advise you to confirm the contents that you submit.
The result of review will be notified all candidates via e-mail. Please make sure to register accurate e-mail address.
6. Category of Regular Submission
We accept submission of English abstracts to regular session.
【Clinical Nephrology】 101 Primary Glomerular Disease 102 Secondary Glomerular Disease 103 Nephrotic Syndrome 104 Diabetes Mellitus 105 Tubulointerstitial Disease 106 Hereditary Disease 107 Urological Disease 108 Water/Electrolyte/Acid-Base Disorders 109 Hypertension: Clinical 110 Vasoactive Substance/Bio-Marker 111 Bone Metabolism: Clinical 201 Acute Renal Failure 202 Chronic Renal Failure 203 Hemodialysis 204 Peritoneal Dialysis 205 Plasma Exchange/Apheresis/Others 206 Kidney Transplantation 207 Clinical Epidemiology/Clinical Research 208 Education and health guidance for CKD 209 Community Health Care 210 Others |
【Immunity/Inflammation/Pathology/Hormone】 301 Nephritis/Nephrosis: Basic 302 Extracellular Matrix/Fibrosis 303 Immunity/Inflammation 304 Hormone/Cell Signaling 305 Others |
【Pathophysiology】 401 Acute Renal Failure: Basic 402 Chronic Renal Failure: Basic 403 Diabetic Nephropathy: Basic 404 Drug-induced Nephropathy: Basic 405 Hypertension: Basic/Renal Hemodynamics 406 Bone Metabolism: Basic 407 Others |
|
【Physiology/Metabolism】 501 Water/electrolyte/solute Transport 502 Acid/Base Metabolism 503 Renal Metabolism 504 Others |
|
【Genetics/Development/Regeneration】 601 Genetics/Development 602 Stem Cells/Regeneration 603 Others |
7. Keyword
Please state up to three keywords of your abstract. (at least one keyword is mandatory)
8. Submit, Confirm and Modify Abstracts
Regular Submission
Regular submission is closed.
Non SSL (If you cannot use cipher-text-based.)
Registration|Confirm・Modify